Links to all GeneRIF Items | 4436 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 17566596 (MSH2) | the T/T genotype of hMSH2 gIVS12-6T>C polymorphism was a poor prognostic factor in non-small cell lung cancer |
| 21093954 (MSH2) | no association between genetic polymorphism and the lung cancer risk |
| 22806311 (MSH2) | MiR-21 expression was inversely correlated with hMSH2 expression in human lung cancer cell lines. |
| 24185125 (MSH2) | MSH2 was reduced in 23.4% of non-small-cell lung carcinoma patients and was significantly associated with adenocarcinoma. |
| 24530475 (MSH2) | Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in non-small-cell lung cancer. |
| 25490383 (MSH2) | MSH2 expression downregulation by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells |
| 28093084 (MSH2) | Findings indicate that carriers of the MSH5 rs707939 T allele, the MSH2 rs6544991 C allele, the MSH3 rs6151627 and rs6151670 G alleles, and the MSH3 rs7709909 T allele have poor toxicity tolerance to platinum-based chemotherapy in non-small cell lung cancer patients. |
| 32211850 (MSH2) | DNMT1 promotes cell proliferation via methylating hMLH1 and hMSH2 promoters in EGFR-mutated non-small cell lung cancer. |